JohnDwyerPowderlyIIMD
Oncology • Huntersville, NCAssistant Consulting Professor in the Department of Medicine, Duke University
Are you Dr. Powderly?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9801 Kincey Ave
Suite 145
Huntersville, NC 28078Phone+1 704-947-6599Fax+1 704-947-6597
Summary
- Dr. John Powderly II, MD is an oncologist in Huntersville, North Carolina. He is currently licensed to practice medicine in North Carolina and Texas. He is an Assistant Consulting Professor in the Department of Medicine at Duke University.
Education & Training
Georgetown University School of MedicineClass of 1995
Certifications & Licensure
NC State Medical License 2000 - 2025
TX State Medical License 1997 - 2001
Publications & Presentations
PubMed
- Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study.Aung Naing, Amit Mahipal, Milind Javle, Judy Wang, Todd M Bauer
Journal of Immunotherapy and Precision Oncology. 2025-02-01 - Phase I dose escalation study of IO-108, an anti-LILRB2 antibody, in patients with advanced solid tumors.Matthew H Taylor, Aung Naing, John Powderly, Paul Woodard, Luke Chung
Journal for Immunotherapy of Cancer. 2024-11-20 - 3 citationsFirst-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors.Mark Yarchoan, John D Powderly, Bruno R Bastos, Thomas B Karasic, Oxana V Crysler
Cancer Research Communications. 2024-04-18
Press Mentions
Tempest Therapeutics' Oncology Programs Presented at Society of Immunotherapy for Cancer Annual MeetingNovember 8th, 2019
Community Practices Say Moonshot May SputterMarch 4th, 2016
